Company Description
Call it The Silence of the Genes. Alnylam Pharmaceuticals runs interference with RNA to prevent disease. RNA...
Key Alnylam Financials
| Company Type | Public - NASDAQ (GM): ALNY Main Headquarters |
|---|---|
| Fiscal Year-End | December |
| 2007 Sales (mil.) | $50.9 |
| 2005 Employees | 94 |
More Alnylam Financials (11 pages)
Latest Alnylam Jobs jobs by Indeed
Competition
Competitive Landscape for Chemicals
Demand is driven by the health of the US economy because chemicals are used to make a wide variety of industrial and consumer products. The profitability of individual companies is closely tied to...
Read more about Alnylam's competition across multiple industries
Top Alnylam Competitors
Sponsored Links
The Business Directory
Alnylam Executives
| Title | Name & Bio | Contact |
|---|---|---|
| Chairman | John K. Clarke | Network | E-mail |
| CEO and Director | John M. Maraganore | Network | E-mail |
| President and COO | Barry E. Greene | Network | E-mail |
| Are You Listed On Hoover's? | ||
|---|---|---|
| Hoover's subscribers also get access to information on people who have self-listed with this company. Subscribers also have the option to add themselves to this company record. |
Tools from our advertising partners:
Current Alnylam News
- BioWorld Today August 20, 2008 [BioWorld Today] (20 Aug 2008 00:01:00 EDT)
- Briefing.com: Hourly In Play (R) - 23:00 ET [Briefing.com] (19 Aug 2008 23:00:00 EDT)
- Briefing.com: Hourly In Play (R) - 22:00 ET [Briefing.com] (19 Aug 2008 22:00:00 EDT)
Sponsored Opportunity
